Inhalable Drug Delivery Pipeline Analysis: Emerging Players, Clinical Trials, and Future Prospects
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Inhalable Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies" report has been added to * ResearchAndMarkets.com's* offering.
This report provides comprehensive information about the Inhalable Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
An Inhalable Drug Delivery device is meant to administer medications that are to be inhaled deeply into the lungs. Drugs are delivered either by the nasal or oral respiratory route.
*Scope*
· Extensive coverage of the Inhalable Drug Delivery under development
· The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
· The report reviews the major players involved in the development of Inhalable Drug Delivery and list all their pipeline projects
· The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
· The report provides key clinical trial data of ongoing trials specific to pipeline products
· Recent developments in the segment / industry
*Reasons to Buy*
*The report enables you to:*
· Formulate significant competitor information, analysis, and insights to improve R&D strategies
· Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
· Identify and understand important and diverse types of Inhalable Drug Delivery under development
· Develop market-entry and market expansion strategies
· Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
· In-depth analysis of the product's current stage of development, territory and estimated launch date
*Companies Mentioned*
· Ablynx NV
· Acorda Therapeutics Inc
· Actervis GmbH
· Aeon Research & Technology
· Aerami Therapeutics Inc
· Aerophase Inc
· AFT Pharmaceuticals Ltd
· Alexza Pharmaceuticals Inc
· Ayuda Medical LLC
· Baby's Breath Ltd
· Baxter International Inc
· Bellerophon Therapeutics Inc
· Breath Therapeutics Holding BV
· Bridgesource Medical Corp
· California Northstate University College of Medicine
· Canigma A.L LTD
· Cognigenics Inc
· Creare LLC
· Cybin Inc
· Department of Biomedical Engineering Columbia University
· DesignWise Medical Inc (Inactive)
· Edixomed Ltd
· HCmed Innovations Co Ltd
· HOLLO Medical Inc
· iDTx Systems, Inc.
· Impel Pharmaceuticals Inc
· Inhalation Sciences Sweden AB
· Invero Pharma LLC
· Jupiter Research LLC
· KAER Biotherapeutics Corp
· Kanabo Research Ltd
· Lupin Pharmaceuticals Inc
· Mallinckrodt Plc
· Marquette University
· Medspray BV
· Monash University
· Nemera La Verpilliere
· Next Safety, Inc.
· Nob Hill Therapeutics Inc
· Nobilis Therapeutics Inc
· Omron Healthcare Co Ltd
· Omron Healthcare Inc
· OncoSec Medical Inc
· PARI GmbH
· Parion Sciences Inc
· Pharmosa Biopharm Inc
· Respira Technologies Inc
· Rhinomed Ltd
· Risproly
· RMIT University
· Rutgers Cancer Institute of New Jersey
· Sandoz International GmbH
· Shenzhen Smoore Technology Ltd
· Sino Biopharmaceutical Ltd
· SolAeroMed Inc
· Stevanato Group
· Stirling Pharma Inc
· Suzhou Wulian Medical Technology Co Ltd
· Technology Commercialization Partners LLC
· Teleflex Inc
· Tetra Bio-Pharma Inc
· Teva Pharmaceutical Industries Ltd
· Texas Tech University Health Sciences Center
· Third Pole Inc
· Tiziana Life Sciences PLC
· University Hospital Southampton NHS Foundation Trust
· University of California San Diego
· University of Texas Health Science Center at Houston
· University of Texas Medical Branch at Galveston
· Vectura Group Plc
· Veoli Ltd
· Vero Biotech LLC
· Verona Pharma Plc
· Via Therapeutics LLC
· Vincent Medical Holdings Ltd
· Virpax Pharmaceuticals Inc
· VistaGen Therapeutics Inc
· VitalMIST
· Wellfully Ltd
· Wellinks Inc
· Windtree Therapeutics Inc
For more information about this report visit https://www.researchandmarkets.com/r/did2jn
Source: GlobalData
*About ResearchAndMarkets.com*
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900